Hospital Universitario De La Princesa
Madrid, Spain
Rare diseases
Investigational molecules
Locations
A plain-language summary of the goals, design and what participants do
This study is being conducted to evaluate the bioequivalence of two different versions of hydrochlorothiazide. This medication is a type of diuretic, which is a substance used to help the body remove excess water and salt through urination. The study compares a test version of the tablet against a known commercial version of the same medicine.
The research involves healthy volunteers who will take a single oral dose, meaning the medicine is swallowed, while in a fasting state, which means not eating or drinking anything except water for a certain period before the test. The participants will undergo a crossover process, where they receive different treatments at different times during the study period to allow for a direct comparison between the two formulations.
The trial runs in 2 steps – from screening to follow-up. Each step says what happens and what the team monitors.
8 criteria
17 criteria
Tell us about your condition – we search every trial in Europe and connect you with the right site.
We usually reply within a few days
All sites with verified contact details – recruitment status may not be available; ask directly
Madrid, Spain
Where you can join this trial
Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.
Not recruitingJoining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.
Hydrochlorothiazide is a medication that acts as a diuretic, often called a "water pill." It works by helping the body get rid of extra salt and water through urine, which helps manage fluid levels.
sourced from the EU Clinical Trials Register and site verification
Want to learn more about this trial or check if you can participate?
Tell us about your condition – we search every trial in Europe and connect you with the right site.